- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07463066
Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder.
Long-Term Outcomes at Five Years Following Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder: Observational Follow-Up of a Randomized Controlled Trial.
The goal of this observational follow-up study is to learn whether the benefits of Pain Neuroscience Education are maintained five years after the original intervention in women previously diagnosed with Genito-Pelvic Pain/Penetration Disorder who participated in a randomized controlled trial.
The main questions it aims to answer are:
Are improvements in pain intensity maintained five years after the intervention? Are improvements in sexual function and pain-related disability sustained over time?
Researchers will compare participants according to the treatment group to which they were originally assigned in the randomized controlled trial to evaluate long-term differences in outcomes.
Participants will:
Complete questionnaires assessing pain intensity, sexual function, and pain-related outcomes. Undergo follow-up assessments similar to those performed during the original study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Genito-Pelvic Pain/Penetration Disorder is a chronic pain condition that significantly affects physical, emotional, and sexual well-being. Women experiencing persistent pelvic pain frequently report difficulties related not only to pain intensity but also to sexual function, fear of movement or penetration, and reduced quality of life. Despite its high impact, conservative treatment approaches remain underutilized, and long-term management strategies are still being explored.
Pain Neuroscience Education (PNE) has emerged over the last decade as a therapeutic approach aimed at helping patients understand the neurophysiological mechanisms underlying persistent pain. By reconceptualizing pain as a multifactorial and modifiable process rather than solely a marker of tissue damage, PNE seeks to reduce fear, maladaptive beliefs, and pain-related disability. Growing evidence supports its short- and medium-term effectiveness in various chronic pain populations.
Five years ago, a multi-centered randomized controlled trial evaluated the effectiveness of a structured Pain Neuroscience Education program in women diagnosed with Genito-Pelvic Pain/Penetration Disorder. The intervention was delivered through different educational modalities and demonstrated clinically relevant improvements following treatment.
However, evidence regarding the durability of these effects over extended periods remains limited. Long-term follow-up studies are essential to determine whether educational interventions targeting pain processing produce sustained changes in pain perception, functional outcomes, and overall well-being.
The present study is designed as a long-term observational follow-up of the original randomized controlled trial cohort. No new intervention will be administered. Instead, participants who were previously enrolled will be reassessed five years after completion of the initial intervention in order to evaluate the persistence of treatment-related changes over time.
This study will contribute to understanding the long-term trajectory of women treated with Pain Neuroscience Education for persistent pelvic pain and will help clarify the potential role of educational strategies as durable components of conservative pain management.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Valencia
-
Valencia, Valencia, Spain, 46010
- Faculty of Physiotherapy. University of Valencia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Study participants will be selected from the cohort of women previously enrolled in a randomized controlled trial evaluating Pain Neuroscience Education for Genito-Pelvic Pain/Penetration Disorder. The source population consists of adult women diagnosed with Genito-Pelvic Pain/Penetration Disorder who were originally recruited from clinical settings for the parent study.
Eligible participants are women aged 18 years or older who are able to read and understand Spanish and provide informed consent. The population includes individuals with varying demographic and clinical characteristics, such as age, marital status, duration of symptoms, pain severity, and baseline functional status. All participants completed the original intervention protocol and will be contacted for long-term follow-up assessment.
Description
Inclusion Criteria:
- Patients over 18 years-old suffering from pelvic pain for more than 6 months
Exclusion Criteria:
- Patients suffering from a previous medical condition that explains logically the presence of pain
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
In person workshops
This group will attend in person workshops were the educational program will be developed.
These workshops will be available in several sites, and specific care providers will be assigned for each of these sites.
|
Several in person workshops given by a researcher
|
|
Online-accessed material
This group will be granted online access to a platform were the educational program will be uploaded.
They will be given autonomy regarding when to enter the platform and view the content.
|
Access to a website containing the educational program
|
|
Control group
This group will initially no recieve an intervention and will serve as a control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numerical Pain Rating Scale
Time Frame: Baseline
|
Pain intensity assessment instrument.
Minimum value 0, maximum value 10.
Higher scores mean worse outcome
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Catastrophizing Scale
Time Frame: Baseline
|
Instrument developed quantify an individual's pain experience.
Minimum value 0, maximum value 52.
Higher scores mean worse outcome.
|
Baseline
|
|
Survey of Pain Attitudes
Time Frame: Baseline
|
Instrument to understand the pain-related beliefs of your chronic pain patients.
Minimum value 0, maximum value 285.
Higher scores mean better results.
|
Baseline
|
|
Female Sexual Function Index
Time Frame: Baseline
|
Inventory designed to assess female sexual function.
Minimum value 2, maximum value 36.
Higher scores mean better functioning.
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UV-INV_ETICA-1741806-FU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genito-Pelvic Pain/Penetration Disorder
-
Riphah International UniversityCompletedGenito-Pelvic Pain/Penetration DisorderPakistan
-
University of ValenciaCompletedGenito-Pelvic Pain/Penetration DisorderSpain
-
Istanbul University - Cerrahpasa (IUC)CompletedPregnancy | Genito-Pelvic Pain | Pelvic Floor Muscle ExerciseTurkey
-
GTO Pharmaceutical, LLCTerminatedFemale Sexual Dysfunction | Vulvovaginal Atrophy | Vulvodynia | Dyspareunia | Vestibulodynia | Postmenopausal Symptoms | Arousal Disorders, Sexual | Genito-Pelvic Pain/Penetration Disorder | Female Sexual Arousal Disorder | Sexual Pain DisordersUnited States
-
Medstar Health Research InstituteRecruitingPelvic Pain | Dyspareunia | Vestibulodynia | Genito-Pelvic Pain/Penetration Disorder | Vaginismus | Vulvodynia (Chronic Vulvar Pain)United States
-
Mayo ClinicCompletedThe Impact of Integrative Medicine on Patient-Reported Outcomes in Management of Chronic Pelvic PainChronic Female Pelvic Pain Syndrome (Disorder)United States
-
Haute Ecole de Santé VaudLa Tour HospitalNot yet recruitingPregnancy | Pelvic Girdle Pain | Pelvic Floor Dysfunctions
-
University of California, San FranciscoStanford University; National Center for Complementary and Integrative Health...CompletedPelvic Pain | Chronic Pelvic Pain | Recurrent Pelvic PainUnited States
-
Foundation University IslamabadActive, not recruitingPregnancy Related Pelvic Girdle PainPakistan
-
SoLa Pelvic TherapyUroshape LLCRecruitingChronic Pelvic Pain | Chronic Pelvic Pain Syndrome (CPPS)United States
Clinical Trials on Online-accessed material
-
University of ValenciaCompletedPain | Dysfunction SexualSpain
-
Abu Dhabi Health Services CompanyEnrolling by invitationAdolescent HealthUnited Arab Emirates
-
University of California, San FranciscoCompleted
-
Cedars-Sinai Medical CenterCompleted
-
The University of Hong KongRecruiting
-
University GhentCompletedPressure Ulcer | Prone PositionBelgium
-
Braintree LaboratoriesCompletedConstipationUnited States
-
University of British ColumbiaChild and Family Research InstituteCompletedWounds and InjuriesCanada
-
New York State Psychiatric InstituteBrown University; Medical Research Council, South AfricaCompleted
-
Ahmet KoçyiğitCompleted